Aehr Test Systems (NASDAQ:AEHR – Get Free Report) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totalling 4,840,000 shares, a decrease of 12.2% from the August 31st total of 5,510,000 shares. Based on an average daily trading volume, of 1,050,000 shares, the short-interest ratio is currently 4.6 days.
Analysts Set New Price Targets
AEHR has been the subject of a number of recent analyst reports. TheStreet upgraded shares of Aehr Test Systems from a “c+” rating to a “b” rating in a research report on Tuesday, August 29th. Craig Hallum upped their price target on shares of Aehr Test Systems from $45.00 to $60.00 in a research report on Friday, July 14th. Finally, StockNews.com initiated coverage on shares of Aehr Test Systems in a research report on Thursday, August 17th. They issued a “hold” rating for the company.
Aehr Test Systems Stock Performance
Shares of NASDAQ:AEHR opened at $45.70 on Friday. The firm has a fifty day moving average price of $47.08 and a 200 day moving average price of $39.16. Aehr Test Systems has a fifty-two week low of $13.61 and a fifty-two week high of $54.10. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 91.40 and a beta of 2.02.
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) last issued its earnings results on Thursday, July 13th. The semiconductor company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. Aehr Test Systems had a net margin of 22.41% and a return on equity of 23.07%. The firm had revenue of $22.27 million during the quarter, compared to analyst estimates of $21.30 million. As a group, research analysts predict that Aehr Test Systems will post 0.94 earnings per share for the current year.
Insider Buying and Selling at Aehr Test Systems
In other Aehr Test Systems news, CEO Gayn Erickson sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $45.00, for a total transaction of $2,250,000.00. Following the completion of the sale, the chief executive officer now directly owns 550,033 shares of the company’s stock, valued at $24,751,485. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Aehr Test Systems news, CEO Gayn Erickson sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $45.00, for a total value of $2,250,000.00. Following the completion of the transaction, the chief executive officer now directly owns 550,033 shares in the company, valued at $24,751,485. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Howard T. Slayen sold 5,352 shares of the company’s stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $52.82, for a total transaction of $282,692.64. Following the completion of the transaction, the director now owns 186,875 shares of the company’s stock, valued at $9,870,737.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 428,543 shares of company stock valued at $21,567,026. Insiders own 11.30% of the company’s stock.
Hedge Funds Weigh In On Aehr Test Systems
Several institutional investors have recently bought and sold shares of the business. Concentrum Wealth Management lifted its position in Aehr Test Systems by 2.4% during the second quarter. Concentrum Wealth Management now owns 15,556 shares of the semiconductor company’s stock valued at $642,000 after purchasing an additional 360 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in Aehr Test Systems by 2.1% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 18,655 shares of the semiconductor company’s stock valued at $770,000 after purchasing an additional 385 shares during the last quarter. Royal Bank of Canada lifted its position in Aehr Test Systems by 1.1% during the second quarter. Royal Bank of Canada now owns 45,431 shares of the semiconductor company’s stock valued at $1,874,000 after purchasing an additional 477 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Aehr Test Systems by 93.0% during the second quarter. PNC Financial Services Group Inc. now owns 1,158 shares of the semiconductor company’s stock valued at $48,000 after purchasing an additional 558 shares during the last quarter. Finally, Commonwealth Equity Services LLC lifted its position in Aehr Test Systems by 3.7% during the second quarter. Commonwealth Equity Services LLC now owns 17,517 shares of the semiconductor company’s stock valued at $723,000 after purchasing an additional 628 shares during the last quarter. Institutional investors own 67.80% of the company’s stock.
Aehr Test Systems Company Profile
Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.